Related references
Note: Only part of the references are listed.Is Progression From Paroxysmal to Sustained Atrial Fibrillation Bad News?
Hisashi Ogawa et al.
CIRCULATION JOURNAL (2022)
Sacubitril/Valsartan Decreases Atrial Fibrillation Susceptibility by Inhibiting Angiotensin II-Induced Atrial Fibrosis Through p-Smad2/3, p-JNK, and p-p38 Signaling Pathways
Song-nan Li et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2022)
Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients
Liu Yang et al.
ESC HEART FAILURE (2022)
Comparing the efficacy of angiotensin receptor-neprilysin inhibitor and enalapril in acute anterior STEMI patients after primary percutaneous coronary intervention: a prospective randomized trial
Youzheng Dong et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2022)
ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
Jianqing She et al.
ESC HEART FAILURE (2022)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Comparison of the Efficacy and Safety of Sacubitril/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction
Ahmed Rezq et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
M. A. ap Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effects of Angiotensin Receptor-Neprilysin Inhibitor in Arrhythmogenicity Following Left Atrial Appendage Closure in an Animal Model
Wen-Han Cheng et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
Jianqing She et al.
ESC HEART FAILURE (2021)
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Domingo Pascual-Figal et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation
Lu-yi-fei Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Sacubitril/Valsartan Therapy Ameliorates Ventricular Tachyarrhythmia Inducibility in a Rabbit Myocardial Infarction Model
Po-Cheng Chang et al.
JOURNAL OF CARDIAC FAILURE (2020)
Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy A Translational Perspective
Stanley Nattel et al.
CIRCULATION RESEARCH (2020)
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Akshay S. Desai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network
Kazuomi Kario et al.
JOURNAL OF CLINICAL HYPERTENSION (2019)
Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices
Jonathan P. Piccini et al.
EUROPACE (2019)
Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study
Deanna G. Cheung et al.
JOURNAL OF CLINICAL HYPERTENSION (2018)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
JOURNAL OF CARDIAC FAILURE (2017)
Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review
Hai Deng et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines
Nicolas Venteclef et al.
EUROPEAN HEART JOURNAL (2015)
Cardiac Sarcoplasmic Reticulum Calcium Leak: Basis and Roles in Cardiac Dysfunction
Donald M. Bers
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression
Jordi Heijman et al.
CIRCULATION RESEARCH (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Novel molecular targets for atrial fibrillation therapy
Dobromir Dobrev et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model
Marc D. Lemoine et al.
CARDIOVASCULAR RESEARCH (2011)
Atrial Fibrillation and Atrial Fibrosis
Alex Y. Tan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
20-Hydroxyeicosatetraenoic Acid Induces Apoptosis in Neonatal Rat Cardiomyocytes Through Mitochondrial-Dependent Pathways
Yuyan Bao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Left-to-Right Atrial Inward Rectifier Potassium Current Gradients in Patients With Paroxysmal Versus Chronic Atrial Fibrillation
Niels Voigt et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2010)
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
Jessie Gu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Progression From Paroxysmal to Persistent Atrial Fibrillation Clinical Correlates and Prognosis
Cees B. de Vos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
In Humans, Chronic Atrial Fibrillation Decreases the Transient Outward Current and Ultrarapid Component of the Delayed Rectifier Current Differentially on Each Atria and Increases the Slow Component of the Delayed Rectifier Current in Both
Ricardo Caballero et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Atrial Arrhythmias in Long-QT Syndrome under Daily Life Conditions: A Nested Case Control Study
Stephan Zellerhoff et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2009)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial-fibrillation: Results from the Canadian Registry of Atrial Fibrillation
CR Kerr et al.
AMERICAN HEART JOURNAL (2005)
L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases
T Christ et al.
CIRCULATION (2004)
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways
S Cardin et al.
CARDIOVASCULAR RESEARCH (2003)
Atrial amyloidosis -: An arrhythmogenic substrate for persistent atrial fibrillation
C Röcken et al.
CIRCULATION (2002)
Share Paper
